IceCure Medical Price to Free Cash Flow Ratio 2020-2024 | ICCM

IceCure Medical price to free cash flow ratio from 2020 to 2024. Price to free cash flow ratio can be defined as

IceCure Medical Price to Free Cash Flow Ratio 2020-2024 | ICCM

IceCure Medical price to free cash flow ratio from 2020 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Elevance Health (ELV)$121.5B
Cencora (COR)$44.3B
ICON (ICLR)$23.6B
DiDi Global (DIDIY)$23.3B
Avantor (AVTR)$17.6B
Natera (NTRA)$15.5B
Revvity (RVTY)$15.5B
Viatris (VTRS)$13.8B
CochLear (CHEOY)$12.8B
Solventum (SOLV)$11.7B
Medpace Holdings (MEDP)$10.3B
Charles River Laboratories (CRL)$10.2B
Sonic Healthcare (SKHHY)$9.1B
Doximity (DOCS)$8B
HealthEquity (HQY)$7B
Bausch + Lomb (BLCO)$6.7B
PACS (PACS)$6B
Organon (OGN)$4.9B
Life Times (LTH)$4.8B
Sotera Health (SHC)$4.7B
Surgery Partners (SGRY)$4.1B
Concentras Parent (CON)$2.8B
Ardent Health Partners (ARDT)$2.6B
GoodRx Holdings (GDRX)$2.6B
BrightSpring Health Services (BTSG)$2.6B
Alignment Healthcare (ALHC)$2.2B
Premier (PINC)$2B
Ryman Healthcare (RYHTY)$2B
AMN Healthcare Services Inc (AMN)$1.6B
CareDx (CDNA)$1.6B